Compare NRIM & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRIM | CRMD |
|---|---|---|
| Founded | 1990 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 548.3M | 590.7M |
| IPO Year | 2002 | 2009 |
| Metric | NRIM | CRMD |
|---|---|---|
| Price | $24.34 | $7.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $30.33 | $15.33 |
| AVG Volume (30 Days) | 132.6K | ★ 825.0K |
| Earning Date | 10-26-2026 | 11-11-2026 |
| Dividend Yield | ★ 2.79% | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | ★ 1.29 | 0.72 |
| Revenue | $255,581,000.00 | ★ $311,709,000.00 |
| Revenue This Year | $1.17 | $8.13 |
| Revenue Next Year | $25.45 | N/A |
| P/E Ratio | $18.92 | ★ $10.36 |
| Revenue Growth | 30.43 | ★ 617.03 |
| 52 Week Low | $19.60 | $6.13 |
| 52 Week High | $30.82 | $13.02 |
| Indicator | NRIM | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 38.60 | 43.22 |
| Support Level | $23.74 | $7.08 |
| Resistance Level | $25.27 | $9.01 |
| Average True Range (ATR) | 0.51 | 0.22 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 38.40 | 46.41 |
Northrim BanCorp Inc is a bank holding company operating through three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. The Community Banking segment, which generates the majority of revenue, provides loan and deposit products to business and consumer customers in its market areas. The Home Mortgage Lending segment focuses on the origination and sale of mortgage loans for one-to-four family residential properties, mortgage loan servicing for certain loans sold, and investment in selected residential mortgage loans. The Specialty Finance segment provides factoring, asset-based lending, and alternative working capital solutions to small and medium-sized enterprises and includes SCF and Northrim Funding Services.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.